{"title":"Unraveling the Link Between Bullous Pemphigoid and Neurological Disease: A Single-center Study of 257 Patients","authors":"L.M. Nieto-Benito , R. Suárez-Fernández","doi":"10.1016/j.ad.2024.10.071","DOIUrl":"10.1016/j.ad.2024.10.071","url":null,"abstract":"<div><h3>Background</h3><div>Multiple studies have corroborated the association between bullous pemphigoid (BP) and neurological diseases; patients with both diseases (BP-N) have been associated with a worse prognosis and specific clinical and immunological characteristics, defining a different subtype of BP.</div></div><div><h3>Objectives</h3><div>We aimed to determine the prevalence and characteristics of BP cases with neurological comorbidities (BP-N) and review the related published literature.</div></div><div><h3>Methods</h3><div>We conducted a retrospective, observational study of BP cases treated at a referral center for autoimmune blistering diseases from January 2000 through June 2020.</div></div><div><h3>Results</h3><div>We collected epidemiological, clinical, histopathological, progression and laboratory data from a total of 257 cases, 102 of which were BP-N. Senile dementia, Alzheimer's disease and vascular dementia were the most frequent neurological comorbidities. Compared with cases without neurological comorbidities, BP-N cases had more intense tissue eosinophilia (<em>p</em> <!-->=<!--> <!-->0.012) and higher concentrations of circulating eosinophils (<em>p</em> <!-->=<!--> <!-->0.000), and anti-BP180 IgG antibodies (<em>p</em> <!-->=<!--> <!-->0.007). At the time of data collection, 78 BP-N were deceased.</div></div><div><h3>Conclusions</h3><div>Our case series highlighted the relevance of neurological comorbidities in BP patients; although the pathogenesis is still to be elucidated, the neuroinflammation present in neurodegenerative diseases could explain the neurocutaneous link and the chronological relationship between these entities.</div></div>","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":"116 8","pages":"Pages 807-814"},"PeriodicalIF":2.8,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143952560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
C. Brazão , D. Mancha , L. Sun , M.R. Barreto , L. Marques-Lito , J. Borges-Costa
{"title":"[Artículo traducido] Infecciones mucocutáneas por el virus del herpes simple: estudio de 6 años en el mayor hospital universitario terciario de Portugal","authors":"C. Brazão , D. Mancha , L. Sun , M.R. Barreto , L. Marques-Lito , J. Borges-Costa","doi":"10.1016/j.ad.2025.05.024","DOIUrl":"10.1016/j.ad.2025.05.024","url":null,"abstract":"<div><div>Herpes simplex virus (HSV) infections are widespread among humans. Their diagnosis is predominantly clinical, but its laboratory confirmation is increasingly encouraged. We conducted a 6-year retrospective, observational study of polymerase chain reaction (PCR) confirmed mucocutaneous HSV infections in the largest Portuguese tertiary teaching hospital. Throughout this period, a total of 947 PCR herpesvirus tests in mucocutaneous swabs were performed, 448 of which tested positive (266 for HSV). Regarding the PCR-confirmed mucocutaneous HSV infections, HSV-1 was the main cause of orolabial herpes and HSV-2 of genital herpes. A significant proportion of patients were immunocompromised, demonstrating the risk for herpesvirus infection and reactivation in this setting. HSV-1 genital herpes was more common in women, younger individuals and had a lower rate of recurrences. This study demonstrates the variable clinical spectrum of HSV infections, and the importance of their laboratory confirmation, as the recognition of the specific pathogen may determine optimal management and prognosis.</div></div>","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":"116 8","pages":"Pages T897-T901"},"PeriodicalIF":2.8,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144245623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Artículo traducido] Eficacia de los medicamentos locales de uso común en el tratamiento de la rosácea: evaluación sistemática y metaanálisis","authors":"X. Gao , W. Xiang","doi":"10.1016/j.ad.2025.06.004","DOIUrl":"10.1016/j.ad.2025.06.004","url":null,"abstract":"<div><div>Topical interventions for rosacea are often used to relieve local symptoms. However, currently, there are few articles to systematically analyze the efficacy profile of topical drugs for rosacea. This study aimed to investigate the efficacy profile of widely used topical drugs. To acquire appropriate information from related literature, we looked into 4 databases. Efficacy was appraised with the Investigator Global Assessment, Clinician's Erythema Assessment, Patient's Self-Assessment and Subject Self-Assessment of Rosacea Facial Redness scales. Treatment-emergent adverse events and dermal tolerability were also recorded. According to 21 randomized controlled trials included, a total of 6 topical drugs including minocycline, ivermectin, azelaic acid, metronidazole, brimonidine and oxymetazoline were reported. These drugs are well-tolerated and safe. Ivermectin is more effective than azelaic acid and metronidazole. Azelaic acid has a better efficacy profile than metronidazole according to included studies. Minocycline turned out to be effective improving the symptoms of rosacea. Brimonidine and oxymetazoline both have significant effects on reducing facial redness.</div></div>","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":"116 8","pages":"Pages T863-T875"},"PeriodicalIF":2.8,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144482868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Artículo traducido] Penfigoide ampolloso y comorbilidad neurológica: ¿causa o consecuencia? Estudio retrospectivo unicéntrico de 257 pacientes","authors":"L.M. Nieto-Benito , R. Suárez-Fernández","doi":"10.1016/j.ad.2025.06.002","DOIUrl":"10.1016/j.ad.2025.06.002","url":null,"abstract":"<div><h3>Background</h3><div>Multiple studies have corroborated the association between bullous pemphigoid (BP) and neurological diseases; patients with both diseases (BP-N) have been associated with a worse prognosis and specific clinical and immunological characteristics, defining a different subtype of BP.</div></div><div><h3>Objectives</h3><div>We aimed to determine the prevalence and characteristics of BP cases with neurological comorbidities (BP-N) and review the related published literature.</div></div><div><h3>Methods</h3><div>We conducted a retrospective, observational study of BP cases treated at a referral center for autoimmune blistering diseases from January 2000 through June 2020.</div></div><div><h3>Results</h3><div>We collected epidemiological, clinical, histopathological, progression and laboratory data from a total of 257 cases, 102 of which were BP-N. Senile dementia, Alzheimer's disease and vascular dementia were the most frequent neurological comorbidities. Compared with cases without neurological comorbidities, BP-N cases had more intense tissue eosinophilia (<em>P</em>=.012) and higher concentrations of circulating eosinophils (<em>P</em>=.000), and anti-BP180 IgG antibodies (<em>P</em>=.007). At the time of data collection, 78 BP-N were deceased.</div></div><div><h3>Conclusions</h3><div>Our case series highlighted the relevance of neurological comorbidities in BP patients; although the pathogenesis is still to be elucidated, the neuroinflammation present in neurodegenerative diseases could explain the neurocutaneous link and the chronological relationship between these entities.</div></div>","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":"116 8","pages":"Pages T807-T814"},"PeriodicalIF":2.8,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144324149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
G.G. Dradi, E. Gómez de la Fuente, E. García Zamora
{"title":"[Translated article] Bullous Lesions After Total Knee Arthroplasty","authors":"G.G. Dradi, E. Gómez de la Fuente, E. García Zamora","doi":"10.1016/j.ad.2025.06.007","DOIUrl":"10.1016/j.ad.2025.06.007","url":null,"abstract":"","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":"116 8","pages":"Pages T908-T910"},"PeriodicalIF":2.8,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144493394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Nuevas medidas de prevención en venereología: revisión de la evidencia existente sobre DoxiPrEP/PEP y vacuna 4CMenB","authors":"A. Català , J. Riera , I. Fuertes de Vega","doi":"10.1016/j.ad.2024.11.028","DOIUrl":"10.1016/j.ad.2024.11.028","url":null,"abstract":"<div><div>Sexually transmitted infections (STIs) are increasing in Spain. The traditional strategy for STI control is mainly based on screening and treatment of STIs in patients with risky sexual practices. In recent years, new interesting primary and secondary prevention strategies are being studied to reduce the incidence rate of STIs in high-risk populations. The most interesting one, based on the evidence obtained, is the use of doxycycline and meningococcal B vaccines. Specialists in dermatology and venereology must be informed about these new developments that may have an impact on the way in which STIs are managed worldwide. This is a scientific evidence review of these new interesting primary and secondary prevention strategies to control STIs in a high-risk population.</div></div>","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":"116 8","pages":"Pages 849-862"},"PeriodicalIF":2.8,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143952620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
E. Baselga , J. Bernabeu-Wittel , I. Betlloch Mas , M. Campos Domínguez , A. Carrasco Sanz , J. del Boz , R. de Lucas Laguna , J. del Pozo Losada , A. Hernández Martín , L. Jiménez Montañés , J.C. López Gutiérrez , A. Martín-Santiago , P. Redondo , A. Torrelo Fernández , A. Vicente Villa
{"title":"Actualización del documento de consenso español sobre el hemangioma infantil","authors":"E. Baselga , J. Bernabeu-Wittel , I. Betlloch Mas , M. Campos Domínguez , A. Carrasco Sanz , J. del Boz , R. de Lucas Laguna , J. del Pozo Losada , A. Hernández Martín , L. Jiménez Montañés , J.C. López Gutiérrez , A. Martín-Santiago , P. Redondo , A. Torrelo Fernández , A. Vicente Villa","doi":"10.1016/j.ad.2024.12.025","DOIUrl":"10.1016/j.ad.2024.12.025","url":null,"abstract":"<div><div>This document updates the 2016 Spanish consensus on infantile hemangioma (IH) based on the currently existing scientific medical literature and the experience of a panel of experts. IH is the most frequent pediatric vascular tumor, is often diagnosed clinically, and usually resolves spontaneously. However, in 10%-15% of cases it results in severe complications. Data show that early intervention and long-term treatment improves outcomes, underscoring the need for clear clinical practice guidelines on the management of patients with IH. This update highlights the usefulness of the IHReS scale for IH patient referral, the importance of telemedicine implementation for IH patient care, the safety of beta-blocker therapy, and the extension of propranolol regimens up to 24<!--> <!-->months.</div></div>","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":"116 8","pages":"Pages 837-848"},"PeriodicalIF":2.8,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143952799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Efficacy of Widely Used Topical Drugs for Rosacea: A Systematic Review and Meta-Analysis","authors":"X. Gao , W. Xiang","doi":"10.1016/j.ad.2024.12.026","DOIUrl":"10.1016/j.ad.2024.12.026","url":null,"abstract":"<div><div>Topical interventions for rosacea are often used to relieve local symptoms. However, currently, there are few articles to systematically analyze the efficacy profile of topical drugs for rosacea. This study aimed to investigate the efficacy profile of widely used topical drugs. To acquire appropriate information from related literature, we looked into 4 databases. Efficacy was appraised with the Investigator Global Assessment, Clinician's Erythema Assessment, Patient's Self-Assessment and Subject Self-Assessment of Rosacea Facial Redness scales. Treatment-emergent adverse events and dermal tolerability were also recorded. According to 21 randomized controlled trials included, a total of 6 topical drugs including minocycline, ivermectin, azelaic acid, metronidazole, brimonidine and oxymetazoline were reported. These drugs are well-tolerated and safe. Ivermectin is more effective than azelaic acid and metronidazole. Azelaic acid has a better efficacy profile than metronidazole according to included studies. Minocycline turned out to be effective improving the symptoms of rosacea. Brimonidine and oxymetazoline both have significant effects on reducing facial redness.</div></div>","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":"116 8","pages":"Pages 863-875"},"PeriodicalIF":2.8,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143961984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. López-Pardo Rico , D. Soto-García , C. Peña Penabad , M.D. Sánchez-Aguilar Rojas , Grupo Gallego del melanoma
{"title":"[Artículo traducido] Los patrones de detección del melanoma se relacionan con el espesor de Breslow: el papel del dermatólogo","authors":"M. López-Pardo Rico , D. Soto-García , C. Peña Penabad , M.D. Sánchez-Aguilar Rojas , Grupo Gallego del melanoma","doi":"10.1016/j.ad.2025.05.021","DOIUrl":"10.1016/j.ad.2025.05.021","url":null,"abstract":"","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":"116 8","pages":"Pages T922-T926"},"PeriodicalIF":2.8,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144245622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}